Experiences of over-the-counter codeine misusers and accounts of recovery: A qualitative study in Tasmania, Australia.
codeine
drug misuse
non-prescription drugs
opioid-related disorders
qualitative research
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
06
02
2020
revised:
02
04
2020
accepted:
06
04
2020
pubmed:
6
5
2020
medline:
9
11
2021
entrez:
6
5
2020
Statut:
ppublish
Résumé
There is international concern about misuse of over-the-counter (OTC) codeine, yet few studies have reported the perspectives of misusers themselves. This study explored the experience of OTC codeine misuse and recovery in Tasmania, Australia. Semi-structured telephone interviews were conducted with 15 self-identified long-term users of OTC codeine. The interview guide prompted responses about reasons for codeine use, positive and negative impacts, recovery, identity and codeine accessibility. Transcripts were analysed abductively using qualitative content analysis. Categories that emerged from misuser accounts were aligned to three broad temporal phases: (i) transition to misuse; (ii) growing awareness; and (iii) towards recovery. Salient features of the misuse experience included: initial use for the self-treatment of physical pain; ongoing use to self-medicate physical pain, stress or mental health conditions; a perception of safety of OTC codeine; an insidious transition from use to misuse; growing awareness of a problem over time; support provided by family, friends and the internet; recovery through self-change; and recognition that recovery is an ongoing process. Knowledge and understanding of the experience of OTC codeine misuse and recovery is critical to inform and tailor approaches to prevention and intervention. The findings suggest that strategies to improve the management of pain, stress and mental health, raise self-awareness of problematic use and potential for self-change, and increase social and web-based supports, should be considered when designing health policy initiatives that aim to reduce misuse.
Substances chimiques
Analgesics, Opioid
0
Nonprescription Drugs
0
Codeine
UX6OWY2V7J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
879-887Informations de copyright
© 2020 Australasian Professional Society on Alcohol and other Drugs.
Références
Hedenmalm K, Blake K, Donegan K et al. A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiol Drug Saf 2019;28:1086-96.
Babalonis S, Lofwall MR, Nuzzo PA, Siegel AJ, Walsh SL. Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug Alcohol Depend 2013;129:116-24.
Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European Union: a systematic review of the literature. Eur Addict Res 2012;18:228-45.
Nielsen S, MacDonald T, Johnson JL. Identifying and treating codeine dependence: a systematic review. Med J Aust 2018;208:451-61.
Dada S, Burnhams NH, Van Hout M, Parry CD. Codeine misuse and dependence in South Africa - learning from substance abuse treatment admissions. S Afr Med J 2015;105:776-9.
Nielsen S, Murnion B, Dunlop A et al. Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series. Drug Alcohol Rev 2015;34:304-11.
Nielsen S, Roxburgh A, Bruno R, Lintzeris N, Jefferson A, Degenhardt L. Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. Drug Alcohol Depend 2015;149:212-9.
Cock V, Edmonds C, Cock C. Complications related to chronic supratherapeutic use of codeine containing compound analgesics in a cohort of patients presenting for codeine withdrawal. Drug Alcohol Rev 2018;37:731-7.
McAvoy BR, Dobbin MDH, Tobin CL. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J 2011;124:29.
Robinson GM, Robinson S, McCarthy P, Cameron C. Misuse of over-the-counter codeine-containing analgesics: dependence and other adverse effects. N Z Med J 2010;123:59-64.
Pilgrim JL, Dobbin M, Drummer OH. Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Med J Aust 2013;199:329-31.
Roxburgh A, Hall WD, Burns L et al. Trends and characteristics of accidental and intentional codeine overdose deaths in Australia. Med J Aust 2015;203:299.
Norman IJ, Bergin M, Parry CD, Van Hout MC. Best practices and innovations for managing codeine misuse and dependence. J Pharm Pharm Sci 2016;19:367-81.
Tay EM, Roberts DM. A spotlight on the role, use and availability of codeine and the implications faced. Expert Rev Clin Pharmacol 2018;11:1057-9.
Tobin CL, Dobbin M, McAvoy B. Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom. Aust N Z J Public Health 2013;37:483-8.
Australian Government Department of Health Therapeutic Goods Administration. Scheduling Delegate's Final Decision: Codeine, December 2016 (January 2017). Available at: https://www.tga.gov.au/book/export/html/733546 (accessed January 2020).
Van Hout MC, Norman I. Misuse of non-prescription codeine containing products: recommendations for detection and reduction of risk in community pharmacies. Int J Drug Policy 2016;27:17-22.
Cairns R, Brown JA, Buckley NA. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons Centre. Addiction 2016;111:1848-53.
Carney T, Wells J, Parry CD, McGuinness P, Harris R, Van Hout MC. A comparative analysis of pharmacists' perspectives on codeine use and misuse-a three country survey. Subst Abuse Treat Pr 2018;13:12.
Hill D, McCabe A, Paterson K, Stuart J, Campbell D. Misuse of over the counter medicines in community pharmacies in Scotland. J Subst Use 2018;23:7-13.
Mill D, Johnson JL, Cock V, Monaghan E, Hotham ED. Counting the cost of over-the-counter codeine containing analgesic misuse: a retrospective review of hospital admissions over a 5 year period. Drug Alcohol Rev 2018;37:247-56.
European Monitoring Centre for Drugs and Drug Addiction. Addressing the Misuse of Medicines (2019). Available at: http://www.emcdda.europa.eu/best-practice/briefings/addressing-misuse-medicines_en (accessed December 2019).
Cooper RJ. 'I can't be an addict. I am.' Over-the-counter medicine abuse: a qualitative study. BMJ Open 2013;3:e002913.
Cooper RJ. Respectable addiction: a qualitative study of over-the-counter medicine abuse in the UK. London: Pharmacy Practice Research Trust, 2011.
Van Hout MC, Horan A, Santlal K, Rich E, Bergin M. ‘Codeine is my companion’: misuse and dependence on codeine containing medicines in Ireland. Ir J Psychol Med 2015;35:275-88.
Van Hout MC, Rich E, Dada S, Bergin M. “Codeine is my helper”: misuse of and dependence on codeine-containing medicines in South Africa. Qual Health Res 2017;27:341-50.
Nielsen S, Cameron J, Pahoki S. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective. Int J Pharm Pract 2013;21:161-8.
Nielsen S, Cameron J, Pahoki S. Final report 2010. Over the counter codeine dependence. Melbourne: Turning Point Alcohol and Drug Centre, 2010.
Kirschbaum M, Barnett T, Cross M. Q sample construction: a novel approach incorporating a Delphi technique to explore opinions about codeine dependence. BMC Med Res Methodol 2019;19:101.
Kirschbaum M, Barnett T, Cross M. ‘For pain, no shame’ and ‘my secret solace’: accounts of over-the-counter codeine dependence using Q methodology. Int J Drug Policy 2019;73:121-8.
Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res 2016;26:1753-60.
Graneheim UH, Lindgren B-M, Lundman B. Methodological challenges in qualitative content analysis: a discussion paper. Nurse Educ Today 2017;56:29-34.
Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs 2008;62:107-15.
Kwon JH, Hui D, Bruera E. A pilot study to define chemical coping in cancer patients using the Delphi method. J Palliat Med 2015;18:703-6.
Kwon JH, Tanco K, Park JC, Wong A, Seo L, Liu D. Frequency, predictors, and medical record documentation of chemical coping among advanced cancer patients. Oncologist 2015;20:692-7.
Castañeda A, Lee C-S, Kim Y-C, Lee D, Moon JY. Addressing opioid-related chemical coping in long-term opioid therapy for chronic noncancer pain: a multicenter, observational, cross-sectional study. J Clin Med 2018;7:354.
Bell K, Salmon A. Pain, physical dependence and pseudoaddiction: redefining addiction for 'nice' people? Int J Drug Policy 2009;20:170-8.
Weier M, Farrugia A. ‘Potential issues of morbidity, toxicity and dependence’: problematizing the up-scheduling of over-the-counter codeine in Australia. Int J Drug Policy 2019. https://doi.org/10.1016/j.drugpo.2019.07.033. [Epub ahead of print].
Kwon JH, Tanco K, Hui D, Reddy A, Bruera E. Chemical coping versus pseudoaddiction in patients with cancer pain. Palliat Support Care 2014;12:413-7.
Van Hout MC, Norman I, Rich E, Bergin M. Experiences of codeine use, misuse and dependence: application of Liese and Franz's cognitive developmental model of substance abuse. Behav Cogn Psychother 2017;45:238-52.
Cloud W, Granfield R. Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse 2008;43:1971-86.
Cooper S, Nielsen S. Stigma and social support in pharmaceutical opioid treatment populations: a scoping review. Int J Ment Health Ad 2017;15:452-69.
Carballo JL, Fernández-Hermida JR, Secades-Villa R, Sobell LC, Dum M, García-Rodríguez O. Natural recovery from alcohol and drug problems: a methodological review of the literature from 1999 through 2005. In: Klingemann H, Sobell L, eds. Promoting self-change from addictive behaviors. New York: Springer, 2007:87-101.
Bishop FM. Self-guided change: the most common form of long-term, maintained health behavior change. Health Psychol Open 2018;5:1-14.
Klingemann H, Sobell MB, Sobell LC. Continuities and changes in self-change research. Addiction 2010;105:1510-8.
Klingemann H, Klingemann J. How much treatment does a person need? Self-change and the treatment system. In: Miller P, ed. Evidence-based addiction treatment. New York: Elsevier, 2009:267-86.
Moore BA, Fazzino T, Garnet B, Cutter CJ, Barry DT. Computer-based interventions for drug use disorders: a systematic review. J Subst Abuse Treat 2011;40:215-23.
Guarino H, Fong C, Marsch LA, Acosta MC, Syckes C, Moore SK. Web-based cognitive behavior therapy for chronic pain patients with aberrant drug-related behavior: outcomes from a randomized controlled trial. Pain Med 2018;19:2423-37.
Lincoln YS, Guba EG. Naturalistic inquiry. California: Sage Publications, 1985.
Bradburn NM, Sudman S, Wansink B. Asking questions: the definitive guide to questionnaire design- for market research, political polls, and social and health questionnaires. San Fransisco: John Wiley & Sons, 2004.